Skip to main content

Cancer genes team up

Scientists have long known of the tumor suppressors and oncogenes that kick-start cancer. Now researchers report that downstream genes affected by such mutations act synergistically to further promote cancer progression, according to a study published online in linkurl:Nature;https://www.nature.com/nature/index.html on Sunday (May 25). "When cells convert from normal to cancer," said Hartmut Land from the University of Rochester Medical Center, an author of the study, "you have a forest of [gen

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Scientists have long known of the tumor suppressors and oncogenes that kick-start cancer. Now researchers report that downstream genes affected by such mutations act synergistically to further promote cancer progression, according to a study published online in linkurl:Nature;https://www.nature.com/nature/index.html on Sunday (May 25). "When cells convert from normal to cancer," said Hartmut Land from the University of Rochester Medical Center, an author of the study, "you have a forest of [genetic] changes that arise. It's difficult to understand which are important in the conversion." So Land and colleagues examined the changes in genes regulated by two known linkurl:oncogenic genes,;https://www.the-scientist.com/news/display/43281/ p53 and Ras. Mutations in p53 and Ras changed the expression patterns of 548 genes. The researchers then looked for the subset of those genes that acted synergistically -- whose response to the both mutations was more than the sum of their response to Ras or p53 alone. They then functionally tested these cooperative effects by using short hairpin RNA and cDNA insertions to reverse changes in these "cooperation response genes." They found that in 14 out of 24 cases, reversing the change caused by Ras and p53 mutations reduced tumor formation, with some combinations having a greater effect than others. "To some people this doesn't come as a big surprise," said Wafik El-Deiry a professor of molecular genetics at the University of Pennsylvania School of Medicine who was not involved in the study. The idea that many genes act together to spur cancer is not new. In fact, 25 years ago, in a paper that has been cited nearly 2,500 times, Land himself showed that a skin cell needed more than a single oncogenic mutation to become cancerous. This research shows "some evidence experimentally," for that mechanism, said El-Deiry. Land noted that the current study also "generates a rational approach to find targets" for new treatments, by using existing therapies to modulate the genes downstream of the p53 mutation.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • The Scientist Placeholder Image

    Edyta Zielinska was a senior editor at The Scientist from 2007 to 2013, where she worked closely with scientific illustrators to develop accompanying graphics to illuminate complex concepts. 

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays